In a Phase 2a clinical trial, Columbia researchers found that the drug AEFO117 significantly reduced the effects of cannabis in daily cannabis smokers.
A Columbia study finds that adolescents who use cannabis recreationally are two to four times as likely to develop psychiatric disorders then teens who don’t use cannabis at all.
"There may be wisdom in unlearning the decidedly adult tendency toward shame, guilt, and discontent, in favor of our earlier nature," writes Dr. Nitasha Shetty.
"It's easy to criticize the DSM, but at this point, it represents a system that is as good as we can have, given our current state of knowledge." says Dr. Jeffrey Lieberman.
"[Buprenorphine] is a tremendously powerful medication, saves many lives and prevents overdose, but there is a risk of misuse and diversion, albeit pretty low," says Dr. Francis Levin.
"The number one goal of health tech, unlike other tech, is not to engage and immerse patients in their phones but to support and embolden them in their real lives," writes Dr. Ravi Shah.
Among those on high doses of steroid medications, "between 5 and 18 percent experience significant “mental status changes,” as we call them," writes Dr. Sally Satel.